Overview

Sustiva was a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat HIV-1 infection in people at least three months old. Sustiva was recommended in combination with other antiretroviral medications. Sustiva was not recommended to be taken alone as monotherapy for HIV. Sustiva is also referred to by its drug name, efavirenz.

Sustiva was an antiviral medication of the non-nucleoside reverse transcriptase inhibitor (NNRTI) class. Sustiva was believed to work by preventing HIV from replicating in cells.

How was it taken?

Prescribing information stated that Sustiva was taken once daily. Sustiva came in tablet or capsule forms.

Side effects

The FDA-approved label for Sustiva listed common side effects including rash, vomiting, nausea, dizziness, headache, fatigue, and insomnia. 

Rare but serious side effects listed for Sustiva included pancreatitis and psychiatric symptoms.

For more details about this treatment, visit:

Sustiva – RxList